Specifically in hormone receptor-positive breast cancer, enhanced angiogenesis accelerated tumor growth [2], and overexpression of the vascular endothelial growth factor (VEGF) either by the tumor [3, 4] or stromal cells [5] was associated with hormone-independent growth and resistance to endocrine therapies. Here, VEGFA is linked to breast carcinoma.